Frontiers in Cardiovascular Medicine (Sep 2023)
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
- Irma Bisceglia,
- Maria Laura Canale,
- Nicola Silvestris,
- Giuseppina Gallucci,
- Andrea Camerini,
- Alessandro Inno,
- Massimiliano Camilli,
- Fabio Maria Turazza,
- Giulia Russo,
- Andrea Paccone,
- Raffaella Mistrulli,
- Leonardo De Luca,
- Stefania Angela Di Fusco,
- Luigi Tarantini,
- Fabiana Lucà,
- Stefano Oliva,
- Antonella Moreo,
- Nicola Maurea,
- Vincenzo Quagliariello,
- Giuseppina Rosaria Ricciardi,
- Chiara Lestuzzi,
- Damiana Fiscella,
- Iris Parrini,
- Vito Racanelli,
- Antonio Russo,
- Lorena Incorvaia,
- Fabio Calabrò,
- Giuseppe Curigliano,
- Saverio Cinieri,
- Michele Massimo Gulizia,
- Domenico Gabrielli,
- Domenico Gabrielli,
- Fabrizio Oliva,
- Furio Colivicchi
Affiliations
- Irma Bisceglia
- Integrated Cardiology Services, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
- Maria Laura Canale
- Division of Cardiology, Ospedale Versilia, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy
- Nicola Silvestris
- Unit of Medical Oncology, Department of Human Pathology in Adulthood and Childhood Gaetano Barresi, University of Messina, Messina, Italy
- Giuseppina Gallucci
- Cardio-oncology Unit, Department of OncoHaematology, IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy
- Andrea Camerini
- Department of Medical Oncology, Ospedale Versilia, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy
- Alessandro Inno
- Department of Oncology, Sacro Cuore Don Calabria Hospital (IRCCS), Negrar, Italy
- Massimiliano Camilli
- Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart and Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Fabio Maria Turazza
- Cardiology Department, National Cancer Institute Foundation (IRCCS), Milan, Italy
- Giulia Russo
- SC Patologie Cardiovascolari, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy
- Andrea Paccone
- 0Department of Cardiology, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
- Raffaella Mistrulli
- 1Cardiology Unit, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Lazio, Italy
- Leonardo De Luca
- 2Division of Cardiology, San Camillo-Forlanini Hospital, Rome, Italy
- Stefania Angela Di Fusco
- 3Clinical and Rehabilitation Cardiology Unit, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy
- Luigi Tarantini
- 4Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio-Emilia, Reggio Emilia, Italy
- Fabiana Lucà
- 5Cardiologia Interventistica, Utic, Grande Ospedale Metropolitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
- Stefano Oliva
- 6UOSD Cardiologia di Interesse Oncologico, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy
- Antonella Moreo
- 7Cardio Center De Gasperis, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Nicola Maurea
- 0Department of Cardiology, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
- Vincenzo Quagliariello
- 0Department of Cardiology, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
- Giuseppina Rosaria Ricciardi
- 8Unit of Medical Oncology, Papardo Hospital, Messina, Italy
- Chiara Lestuzzi
- 9Centro Medico Esperia, Porcia (PN), Italy
- Damiana Fiscella
- 0U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione “Garibaldi”, Catania, Italy
- Iris Parrini
- 1Department of Cardiology, Hospital Mauritian Turin, Turin, Italy
- Vito Racanelli
- 2Department of Interdisciplinary Medicine, School of Medicine, University of Bari Aldo Moro, Bari, Italy
- Antonio Russo
- 3Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo University Hospital, Palermo, Italy
- Lorena Incorvaia
- 3Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo University Hospital, Palermo, Italy
- Fabio Calabrò
- 4Department of Oncology and Specialized Medicine, San Camillo-Forlanini Hospital, Rome, Italy
- Giuseppe Curigliano
- 5Department of Oncology and Hemato-Oncology, University of Milan; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milan, Italy
- Saverio Cinieri
- 6Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy
- Michele Massimo Gulizia
- 0U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione “Garibaldi”, Catania, Italy
- Domenico Gabrielli
- 2Division of Cardiology, San Camillo-Forlanini Hospital, Rome, Italy
- Domenico Gabrielli
- 7Fondazione per il Tuo cuore- Heart Care Foundation, Firenze, Italy
- Fabrizio Oliva
- 8Cardiologia 1- Emodinamica, Dipartimento Cardiotoracovascolare “A. De Gasperis”, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Furio Colivicchi
- 3Clinical and Rehabilitation Cardiology Unit, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy
- DOI
- https://doi.org/10.3389/fcvm.2023.1223660
- Journal volume & issue
-
Vol. 10
Abstract
In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.
Keywords
- cancer survivors (CSs)
- cardiovascular disease (CVD)
- cancer therapy-related cardiovascular toxicities (CTR-CVT)
- cardiovascular risk factors (CVRF)
- reverse cardio-oncology
- survivorship care
